Prime Editing: Genome Editing for Rare Genetic Diseases Without Double-Strand Breaks or Donor DNA.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

37 citing papers in PubMed.

1. A comprehensive review of CRISPR-Cas9-mediated genome editing in Leishmania strains: methodologies, applications, challenges and future directions.Molecular biology reports · 2026
   Review
2. Prime editing: Emerging mechanisms, engineering innovations, and next-generation applications.Biodesign research · 2026
   Review
3. The emerging impact of CRISPR and gene editing on global crop improvement.Transgenic research · 2026
   Review
4. Prime Editing Driven Functional Genomics: Bridging Genotype to Phenotype in the Post-Genomic Era.International journal of molecular sciences · 2026
   Review
5. Assessing off-target effects in CRISPR/Cas9: challenges and strategies for precision DNA editing.Archives of microbiology · 2026
   Review
6. An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical limitations.Frontiers in pharmacology · 2026
   Review
7. Beyond Cutting: CRISPR-Driven Synthetic Biology Toolkit for Next-Generation Microalgal Metabolic Engineering.International journal of molecular sciences · 2025
   Review
8. Advancing Precision Medicine: Recent Innovations in Gene Editing Technologies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
   Review
9. Chemical engineering of CRISPR-Cas systems for therapeutic application.Nature reviews. Drug discovery · 2025
   Review
10. Advancing vegetable genetics with gene editing: a pathway to food security and nutritional resilience in climate-shifted environments.Functional & integrative genomics · 2025
    Review
11. Unlocking the potential of 'Egusi' melon (Frontiers in plant science · 2025
    Review
12. Gene Therapy for Inherited Liver Disease: To Add or to Edit.International journal of molecular sciences · 2024
    Review
13. Application of CRISPR/Cas-based gene-editing for developing better banana.Frontiers in bioengineering and biotechnology · 2024
    Review
14. Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing.Biologics : targets & therapy · 2024
    Review
15. Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.Stem cell reviews and reports · 2023
    Review
16. The potential of gene editing for Huntington's disease.Trends in neurosciences · 2023
    Review
17. Prime Editing: An Emerging Tool in Cancer Treatment.Molecular biotechnology · 2023
    Review
18. Prime Editing: An All-Rounder for Genome Editing.International journal of molecular sciences · 2022
    Review
19. Current technological interventions and applications of CRISPR/Cas for crop improvement.Molecular biology reports · 2022
    Review
20. Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases.Cells · 2022
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as